Target intelligence / Profile preview

Bacterial 70S ribosome subunit interface (70S interface)

Target
70S interface
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The bacterial 70S ribosome subunit interface is the critical contact area between the 30S small subunit and the 50S large subunit, mediated by a series of dynamic intersubunit bridges (Liu & Fredrick, 2016). These bridges, primarily formed by ribosomal RNA (rRNA) and some ribosomal proteins, are essential for the assembly of the functional 70S ribosome and its conformational changes during protein synthesis (Yusupov et al., 2001). This interface serves as a major therapeutic target for several classes of antibiotics that disrupt bacterial translation (Wilson, 2014). For instance, oxazolidinones like linezolid bind to the 50S subunit at the interface to prevent the formation of the 70S initiation complex (Swaney et al., 1998). Other antibiotics, such as aminoglycosides and tuberactinomycins, bind near the interface to stabilize or destabilize subunit interactions, leading to misreading of the genetic code or inhibition of translocation (Wang et al., 2012). Because the bacterial 70S ribosome is structurally distinct from the eukaryotic 80S ribosome, these drugs exhibit selective toxicity. However, structural similarities with human mitochondrial ribosomes can lead to clinical side effects like ototoxicity and nephrotoxicity (Böttger et al., 2001). Targeting the interface remains a robust strategy for developing new antimicrobials to combat multi-drug resistant bacterial strains.

Other names
30S-50S interfaceBacterial ribosome intersubunit bridges70S ribosome interfaceRibosomal subunit interface
02

Mechanism of action

Inhibition of 70S initiation complex formation, stabilization of intersubunit bridges to prevent translocation, and interference with ribosomal subunit association and dissociation cycles (Wilson, 2014; Swaney et al., 1998).

03

Biological functions

Protein biosynthesisRibosome assemblyTranslation initiationTranslation elongationTranslation termination
04

Disease associations

Infection
05

Safety considerations

Mitochondrial toxicityOtotoxicityNephrotoxicityAntimicrobial resistanceMyelosuppression (with long-term oxazolidinone use) (Böttger et al., 2001).
06

Interacting drugs

Linezolid

8 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Bacterial loadProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Bacterial 70S ribosome subunit interface (70S interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 70S ribosome subunit interface (70S interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call